Delivery Order HHSN271201600007I-HHSN27100001
Award Date 9/13/16
Potential Completion Date 9/12/20
Potential Value $414K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Birmingham, AL 35205, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Cost Plus Fixed Fee delivery order awarded by the National Institutes of Health (NIH), National Institute on Drug Abuse to SRI International, a non-profit research institute. The contract is for IND-enabling Good Laboratory Practice (GLP) toxicology studies under the Pharmacology and Toxicology for Therapeutics Program (PTTP) Indefinite Delivery, Indefinite Quantity (IDIQ) master contract. The potential value of this particular delivery order is $1,759,706.00, with a completion date of...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Southern Research Institute, a non-profit organization. The $1,593,565.26 contract is under the Pharmacology and Toxicology for Neurotherapeutics Program (PTNP) indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The contract is for the 28-day oral toxicity study in monkeys with a 33-day recovery period. Southern Research Institute has subcontracted a...
- This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to SRI International, a non-profit research institute, for a suite of GLP toxicology studies under the Pharmacology and Toxicology for Therapeutics Program (PTTP) indefinite delivery, indefinite quantity (IDIQ) contract. The contract has a potential value of $2,149,530.00 and a completion date of May 31, 2021. It is not designated as a set-aside...
- This is a federal contract award to IIT Research Institute (IITRI), a non-profit contract research organization, by the National Institute on Drug Abuse (NIDA), a civilian agency. The $442,623.00 contract is a cost-plus-fixed-fee delivery order with no set-aside designation. It is for PTTP TASK ORDER - IITRI - MS RODENT AND NON-RODENT MTD-DRF STUDIES, which involve preclinical drug development services such as pharmacology, toxicology, safety, and efficacy evaluations to support...
- The National Institute on Drug Abuse issued a $312,044 delivery order to Research Triangle Institute on March 20, 2026, for preparation and distribution of research drug products, with performance through June 19, 2026. The order is issued under RTI's $19.9 million Indefinite Delivery Contract with NIDA for preparation and distribution of research drug products, which extends through March 2029. Place of performance is Bethesda, MD. The order carries firm fixed-price pricing with no set-aside.
- This federal contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization. The contract has a ceiling value of $97,075.45 and is a delivery order contract with a firm fixed price pricing type. The contract was awarded on July 29, 2015 and has an ultimate completion date of September 27, 2016. This contract does not have a set-aside designation....
- The National Institute on Drug Abuse issued a delivery order to Technical Resources International, Inc., a minority-owned, woman-owned, and Hispanic American-owned small business, with a ceiling value of $11,400 on June 5, 2026. The order is issued under NIDA's $2.5 million IDV for pharmacokinetic analysis support. This delivery order covers Task Order 4, Pharmacokinetic Analysis Resource Center, Phase III Protocol (STP7), with performance in Westlake, MD from June 5, 2026 through March 4, 2027....
- The National Institute on Drug Abuse awarded a firm fixed price delivery order against its PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS contract to Research Triangle Institute International for $65,862. The order is for work described in the attached statement of work to be performed from May 15, 2020 through May 14, 2021 in Research Triangle Park, North Carolina. No set-aside designation was used for this $63,862 potential value order to provide research support services for the...
- This federal contract award is a delivery order under a larger contract vehicle, with Research Triangle Institute (RTI) International as the prime contractor. The contract is with the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The award, valued at $376,358.00, is for the synthesis and distribution of drugs of abuse and related compounds over a one-year period from June 16, 2024 to June 15, 2025, with a total period of...
- This is a task order for "Continuous Rodent and Non-Rodent Pharmacokinetic Assessments" awarded by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to Southern Research Institute, a non-profit research organization. The task order is part of a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle called the Pharmacology and Toxicology for Therapeutics Program (PTTP), which provides preclinical services to support drug...
- HHSN271201600007IIndefinite Delivery Contract
- HHSN271201600007I-HHSN27100001Delivery Order
This is a firm fixed-price delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Southern Research Institute, a non-profit organization. The order is for $414,199.00 and is part of the Pharmacology and Toxicology for Therapeutics Program (PTTP) Indefinite Delivery/Indefinite Quantity (ID/IQ) contract vehicle. The work will support management and operations for PTTP, which focuses on drug discovery and development, including for emerging infectious diseases, medicinal chemistry, toxicology, and other related areas. This order does not have a set-aside designation.
Generated 4/1/25, 5:02 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Pharmacology and Toxicology for Therapeutics Program (PTTP) | NIH-NINDS-16-01 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 3/4/16, 3:43 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $103.2k | 8/7/19 | |
| 2 | Exercise an Option | $100.2k | 9/10/18 | |
| 1 | Exercise an Option | $97.3k | 8/4/17 | |
| Not listed | Not listed | $113.5k | 9/13/16 |